Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5058576 | 0.87 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL6406979 | 0.84 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL12478071 | 0.80 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL2551787 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL3295337 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL6153672 | 0.77 | ALDH1A1 (0.41) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL8350594 | 0.76 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL2293347 | 0.76 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL5087023 | 0.75 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL530122 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697020-B2 | Silica magnetic particles having a spherical form and a process for preparing the same | BIONEER CORPORATION (KR) | 2014-04-15 | — | — | US | claimed |
| US-20110054162-A1 | Silica Magnetic Particles Having a Spherical Form and a Process for Preparing the Same | BIONEER CORPORATION (KR) | 2011-03-03 | — | — | US | claimed |
| WO-2009102171-A2 | SILICA MAGNETIC PARTICLES HAVING A SPHERICAL FORM AND A PROCESS FOR PREPARING THE SAME | BIONEER CORPORATION (KR) | 2009-08-20 | — | — | WO | claimed |
| WO-2005103172-A2 | DEW RESISTANT COATINGS | AVERY DENNISON CORPORATION (US) | 2005-11-03 | — | — | WO | claimed |
| US-20050233135-A1 | Dew resistant coatings | AVERY DENNISON CORPORATION | 2005-10-20 | — | — | US | claimed |
| EP-1420744-A4 | AMINE COMPOUNDS AND CURABLE COMPOSITIONS DERIVED THEREFROM | VIRGINIA TECH INTELL PROP (US) | 2004-11-24 | — | — | EP | claimed |
| EP-1420744-A2 | AMINE COMPOUNDS AND CURABLE COMPOSITIONS DERIVED THEREFROM | Virginia Tech Intellectual Properties, Inc. (US) | 2004-05-26 | — | — | EP | claimed |
| WO-2003002057-A2 | AMINE COMPOUNDS AND CURABLE COMPOSITIONS DERIVED THEREFROM | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| EP-0757074-B1 | Process of stabilising siloxane polymers | DOW CORNING LTD (GB) | 2002-02-20 | — | — | EP | claimed |
| EP-0757074-A2 | Process of stabilising siloxane polymers | Dow Corning Limited (GB) | 1997-02-05 | — | — | EP | claimed |
| US-20260097584-A1 | LIQUID EJECTION HEAD AND METHOD FOR PRODUCING LIQUID EJECTION HEAD | CANON KK (JP) | 2026-04-09 | — | — | US | disclosed |
| US-11241877-B2 | Transfer body, image recording method and image recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2022-02-08 | — | — | US | disclosed |
| US-20210229418-A1 | TRANSFER MEMBER, INK JET RECORDING METHOD, AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2021-07-29 | — | — | US | disclosed |
| CN-109249720-B | Transfer member for transfer type ink jet recording, ink jet recording method and ink jet recording apparatus | 佳能株式会社 | 2021-05-07 | — | — | CN | disclosed |
| EP-3428237-B1 | TRANSFER MEMBER FOR TRANSFER-TYPE INKJET RECORDING, INKJET RECORDING METHOD AND INKJET RECORDING APPARATUS | CANON KK (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-5238708-A | Alkoxysilane, organotitanate, and a carboxylic acid tin salt | DOW CORNING CORPORATION (US) | 1993-08-24 | — | — | US | disclosed |
| US-5213617-A | Mixture of alkoxysilane, organotitanate and tin salt of carboxylic acid | DOW CORNING CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| US-5209871-A | Reacting a polyether diamine and a epoxysilane, alkali metal salt | FORD MOTOR COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5110890-A | METHOD OF MAKING ORGANISILOXANE RESINS | DOW CORNING LIMITED (GB) | 1992-05-05 | — | — | US | disclosed |
| EP-0389138-A2 | Method of making organosiloxane resins | Dow Corning Limited (GB) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054162-A1 | Silica Magnetic Particles Having a Spherical Form and a Process for Preparing the Same | SPIN3, SPIN1, SPIN4 | ALDH1A1 4230/4885TSHR 3959/4885MAPK1 2187/4885 |
| US-20260097584-A1 | LIQUID EJECTION HEAD AND METHOD FOR PRODUCING LIQUID EJECTION HEAD | SGMS1, SGMS2, F8 | ALDH1A1 4065/4885TSHR 1021/4885MAPK1 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.